Episode
HER2-Altered Non-Small Cell Lung Cancer — Rapid Case Review
- Published
- Jul 14, 2026
- Duration seconds
- 1652
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/oncology-today-with-dr-neil-love-1004241/episodes/her2-altered-non-small-cell-lung-cancer-rapid-case-review/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/oncology-today-with-dr-neil-love-1004241/her2-altered-non-small-cell-lung-cancer-rapid-case-review.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Featuring an interview with Dr Mark Jeng and Dr Joshua K Sabari, including the following topics: Case: A woman in her late 90s with recurrent HER2-mutant metastatic non-small cell lung cancer (NSCLC) receives third-line zongertinib (0:00) Case: A woman in her early 60s with multiregimen-recurrent HER2-mutant metastatic NSCLC experiences a response to zongertinib (8:07) Case: A man in his mid 80s experiences metastatic recurrence after resection of PD-L1-positive, HER2-mutant metastatic NSCLC (17:50) CME information and select publications